Suchergebnisse - "Hanauer, Stephen B"

PubPharm (22)

1

Time to Symptom Resolution in Ulcerative Colitis With Multimatrix Mesalazine Treatment : A Pooled Analysis

enthalten in: Journal of Crohn's & colitis | 2020

von Schreiber, S. | Hanauer, S. | Sandborn, W. | +1

2

Too Soon to Discard 5-ASAs?

enthalten in: The American journal of gastroenterology | 2019

von Gupta, N. | Hanauer, S.

CommentOn: Am J Gastroenterol. 2018 Aug;113(8):1197-1205. - PMID 29925913

3

Oral or Topical 5-ASA in Ulcerative Colitis

enthalten in: Digestive diseases (Basel, Switzerland) | 2016

von Hanauer, S.

4

Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis : a case-control study

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2013

von Rubin, D. | Huo, D. | Kinnucan, J. | +8

5

Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis : a meta-analysis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2012

von Ford, A. | Khan, K. | Sandborn, W. | +2

6

Optimizing conventional therapies for inflammatory bowel disease

enthalten in: Current gastroenterology reports | 2009

von Sparrow, M. | Irving, P. | Hanauer, S.

7

Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis

enthalten in: Gastroenterology | 2009

von Sandborn, W. | Regula, J. | Feagan, B. | +8

CommentIn: Gastroenterology. 2009 Dec;137(6):1880-2. - PMID 19879213

8

Optimizing conventional therapies for inflammatory bowel disease

enthalten in: Current gastroenterology reports | 2009

von Sparrow, M. | Irving, P. | Hanauer, S.

9

Optimizing conventional therapies for inflammatory bowel disease

enthalten in: Current gastroenterology reports | 2009

von Sparrow, M. | Irving, P. | Hanauer, S.

10

Optimizing conventional therapies for inflammatory bowel disease

enthalten in: Current gastroenterology reports | 2009

von Sparrow, M. | Irving, P. | Hanauer, S.